Furthermore, it has been reported that Tak1 deletion in microglia results in alleviation of autoimmune inflammation caused by experimental autoimmune encephalomyelitis and post-ischemic neuroinflammation (Goldmann et al., 2013; Lu et al., 2017; Zeyen et al., 2020). This evidence concerns the gene MAP3K7 and experimental autoimmune encephalomyelitis.